Marjie Hard

1.2k total citations
27 papers, 888 citations indexed

About

Marjie Hard is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Marjie Hard has authored 27 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 8 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Marjie Hard's work include Pharmaceutical studies and practices (9 papers), Schizophrenia research and treatment (6 papers) and Prenatal Substance Exposure Effects (4 papers). Marjie Hard is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Schizophrenia research and treatment (6 papers) and Prenatal Substance Exposure Effects (4 papers). Marjie Hard collaborates with scholars based in United States, Canada and United Kingdom. Marjie Hard's co-authors include Gideon Koren, Caroline Maltepe, Radinka Boskovic, Adrienne Einarson, Yvette Navioz, Lisa Von Moltke, Richard J. Mills, Brian M. Sadler, Angela Wehr and Ryan Z. Turncliff and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Marjie Hard

26 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjie Hard United States 14 241 220 209 150 88 27 888
Johannes Pöschl Germany 19 143 0.6× 201 0.9× 70 0.3× 75 0.5× 79 0.9× 53 1.1k
Anna Bertram Germany 15 131 0.5× 51 0.2× 101 0.5× 69 0.5× 105 1.2× 22 708
Hideo Nakai Japan 16 258 1.1× 220 1.0× 101 0.5× 51 0.3× 77 0.9× 92 1.1k
Nicolas Bouvier France 15 153 0.6× 69 0.3× 78 0.4× 62 0.4× 167 1.9× 54 874
Andrew Nicholls United States 11 345 1.4× 432 2.0× 125 0.6× 605 4.0× 136 1.5× 15 1.9k
Nathan Brand United States 15 300 1.2× 247 1.1× 146 0.7× 300 2.0× 10 0.1× 44 1.1k
Mary K. Samplaski United States 23 630 2.6× 155 0.7× 316 1.5× 92 0.6× 33 0.4× 70 1.8k
Anastasia Garoufi Greece 17 50 0.2× 228 1.0× 89 0.4× 167 1.1× 23 0.3× 65 694
Yanhong Yu China 20 472 2.0× 280 1.3× 201 1.0× 37 0.2× 16 0.2× 46 1.6k
Clemens Grupp Germany 15 258 1.1× 221 1.0× 36 0.2× 27 0.2× 142 1.6× 49 857

Countries citing papers authored by Marjie Hard

Since Specialization
Citations

This map shows the geographic impact of Marjie Hard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjie Hard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjie Hard more than expected).

Fields of papers citing papers by Marjie Hard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjie Hard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjie Hard. The network helps show where Marjie Hard may publish in the future.

Co-authorship network of co-authors of Marjie Hard

This figure shows the co-authorship network connecting the top 25 collaborators of Marjie Hard. A scholar is included among the top collaborators of Marjie Hard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjie Hard. Marjie Hard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Risinger, Robert, Marjie Hard, & Peter J. Weiden. (2025). A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil. Psychopharmacology Bulletin. 47(3). 26–34.
2.
August, Allison, Husain Attarwala, Sunny Himansu, et al.. (2021). A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nature Medicine. 27(12). 2224–2233. 118 indexed citations
3.
Karol, Michael D., et al.. (2021). Mass balance and pharmacokinetics of an oral dose of 14C‐napabucasin in healthy adult male subjects. Pharmacology Research & Perspectives. 9(1). e00722–e00722. 5 indexed citations
4.
5.
Kumar, Vipul, Hong Lü, Marjie Hard, & Lisa Von Moltke. (2019). Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age. Drugs in R&D. 19(3). 277–287. 8 indexed citations
6.
7.
Hard, Marjie, Angela Wehr, Brian M. Sadler, Richard J. Mills, & Lisa Von Moltke. (2018). Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil. European Journal of Drug Metabolism and Pharmacokinetics. 43(4). 461–469. 25 indexed citations
8.
Hard, Marjie, Angela Wehr, Yangchun Du, et al.. (2018). Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia. Journal of Clinical Psychopharmacology. 38(5). 435–441. 15 indexed citations
9.
Wehr, Angela, Marjie Hard, Miao Yu, Richard Leigh-Pemberton, & Lisa Von Moltke. (2018). Relative Bioavailability of Monomethyl Fumarate after Administration of ALKS 8700 and Dimethyl Fumarate in Healthy Subjects (P1.403). Neurology. 90(15_supplement). 8 indexed citations
10.
Li, Zhaoyang, et al.. (2014). Lack of Clinical Pharmacodynamic and Pharmacokinetic Drug–Drug Interactions Between Warfarin and the Antisense Oligonucleotide Mipomersen. Journal of Cardiovascular Pharmacology. 64(2). 164–171. 15 indexed citations
11.
Petri, Camille R., Peter H. O’Donnell, Hongyuan Cao, et al.. (2014). Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant. Leukemia & lymphoma. 55(12). 2866–2873. 15 indexed citations
12.
Turncliff, Ryan Z., Marjie Hard, Yangchun Du, Robert Risinger, & Elliot Ehrich. (2014). Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia. Schizophrenia Research. 159(2-3). 404–410. 33 indexed citations
13.
Trachtman, Howard, Fernando C. Fervenza, Debbie S. Gipson, et al.. (2011). A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney International. 79(11). 1236–1243. 203 indexed citations
14.
Hard, Marjie, Mohamed Abdolell, Brian H. Robinson, & Gideon Koren. (2005). Gene-expression analysis after alcohol exposure in the developing mouse. Journal of Laboratory and Clinical Medicine. 145(1). 47–54. 59 indexed citations
15.
Kozer, Eran, et al.. (2003). Bioavailability of a pediatric amlodipine suspension. Pediatric Nephrology. 18(7). 675–678. 11 indexed citations
16.
Hard, Marjie, Umar Iqbal, James F. Brien, & Gideon Koren. (2003). Binding of Acetaldehyde to Human and Guinea Pig Placentae In Vitro. Placenta. 24(2-3). 149–154. 2 indexed citations
17.
Ray, Joel G., et al.. (2003). In vitro analysis of human transplacental transport of desmopressin. Clinical Biochemistry. 37(1). 10–13. 8 indexed citations
18.
Koren, Gideon, Radinka Boskovic, Marjie Hard, et al.. (2002). Motherisk—PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology. 186(5). S228–S231. 189 indexed citations
19.
Hard, Marjie, et al.. (2001). Impairment of pyruvate dehydrogenase activity by acetaldehyde. Alcohol. 25(1). 1–8. 13 indexed citations
20.
Hard, Marjie, Thomas R. Einarson, & Gideon Koren. (2001). The Role of Acetaldehyde in Pregnancy Outcome After Prenatal Alcohol Exposure. Therapeutic Drug Monitoring. 23(4). 427–434. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Pöschl Breakdown of academic impact, for papers by Anna Bertram Breakdown of academic impact, for papers by Hideo Nakai Breakdown of academic impact, for papers by Nicolas Bouvier Breakdown of academic impact, for papers by Andrew Nicholls Breakdown of academic impact, for papers by Nathan Brand Breakdown of academic impact, for papers by Mary K. Samplaski Breakdown of academic impact, for papers by Anastasia Garoufi Breakdown of academic impact, for papers by Yanhong Yu Breakdown of academic impact, for papers by Clemens Grupp
Rankless by CCL
2026